GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Trulicity are giving consumers control over their hunger. Faced with declining sales, food companies aren’t adapting to this shift. They’re fighting back. Their new strategy? Use AI to re-engineer addiction. Forbes gives the details.


